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populationsAbstract Objectives: To develop a protocol for a scoping review mapping as well as themat-
ically analyzing the literature on the effect of, and responses to, the coronavirus disease 2019
(COVID-19) pandemic, focused on people with disabilities with other layers of individual
vulnerability or social disadvantage.
Methods: We will search scientific databases (Medline/PubMed, Web of Science, Scopus, Age-
Line, PsycINFO, CINAHL, ERIC) and preprint servers (MedRxiv, SocArXiv, PsyArXiv). Google
searches, snowballing, and key-informant strategies were also used, including a focus on the
gray literature (eg, official reports). Peer-reviewed and preprint publications will be covered
in 6 languages, and the gray literature in English. Publications will be included if they address
individuals with disabilities; the COVID-19 pandemic or subsequent socioeconomic or occupa-
tional effects; and individual or social vulnerabilities, including any form of discrimination,
marginalization, or social disadvantage. Two independent reviewers will perform eligibility de-
cisions and key data extractions. Beyond mapping the literature, the results will thematically
analyze any disproportionate risks people with disabilities and other forms of vulnerability
experience in terms of being infected by COVID-19, having severe health consequences, and
facing negative socioeconomic effects. Actions taken or recommended to reduce identified in-
equalities will also be synthesized. Our entire research team, with diverse backgrounds, will be
involved in the synthesis.
Conclusions: This review, which we plan to expedite, aims to inform policy makers, health au-
thorities, disability advocates, and other stakeholders regarding the needs and ways to pro-
mote equity and disability-inclusive responses to the COVID-19 pandemic and the resultant
socioeconomic shockwaves.
ª 2020 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medi-
cine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is the strain of coronavirus disease 2019 (COVID-19)
that caused a recent global public health and economic
crisis of rare proportions. However, the effect of the
COVID-19 pandemic has not been equal across pop-
ulations.1,2 Many populations have been vulnerable,
including but not limited to older individuals and people
with chronic health conditions and disabilities.1,3-6 For
instance, minorities or socially disadvantaged populations
can also be disproportionally affected by COVID-19, such as
African Americans; Hispanics; refugees; migrants; indige-
nous people; uninsured individuals; prisoners; and those
who are institutionalized, homeless, resource-poor, living
in densely populated communities or households, frontline
essential workers (ie, unable to telework), and who have no
access to soap or clean water.1,2,5,7-15 These are just a few
examples of social disadvantages or vulnerabilities,
entrenched as societal injustices, which add to individual
vulnerabilities to the COVID-19 pandemic.2,14 Vulnerability
to the COVID-19 pandemic can be reflected in terms of
greater exposure to or risk of being infected, not having
timely access to COVID-19 diagnostic tests, not being able
to access health care once infected, or experiencing morefrequent or severe health and socioeconomic conse-
quences, even without being infected.8,16-18
Overall, the COVID-19 pandemic can have a greater
negative effect on the socially disadvantaged as well as
directly or indirectly exacerbate health and other in-
equalities among populations within and across countries, if
no protective action is taken.1,16,19-21
People with disabilities (PwD) may also be especially
vulnerable to the effects of the COVID-19 pandemic. In
this article, we use person first language to convey that
disability does not define people. We have abbreviated
“people with disability” to “PwD” simply for brevity. The
term PwD refers to a minority group that is vulnerable to
discrimination and marginalization, even in nonpandemic
times. For instance, it has been vastly documented that
PwD experience disparities in health and health care
access, as well as health care quality and outcomes.22-26
Moreover, PwD typically experience additional health
care and living costs, lower employment rates, and less
disposable income than their nondisabled counter-
parts,27-35 which adds to a continuous cycle between
poverty and disability that remains unresolved by
societies.24,32
Disability and COVID-19 vulnerabilities 3In the current pandemic, PwD are more likely to be
disproportionally affected by the COVID-19 pandemic in a
myriad of ways.36-38 People with intellectual, develop-
mental, mobility, or multiple impairments may have
greater odds of being infected owing to difficulties in un-
derstanding or otherwise complying with preventive mea-
sures such as physical distancing, effective handwashing, or
wearing masks.36,37 Furthermore, people with intellectual,
visual, or hearing impairments may not be able to comply
with public health recommendations when these are pro-
vided in inaccessible forms (eg, verbally through opaque
masks).37 In many societies, PwD are institutionalized and
hence greatly exposed to physical contacting risks.5,39,40
PwD can also disproportionally experience the conse-
quences of a COVID-19 infection, as they often have greater
rates of chronic or secondary health conditions,31,41-43
including those related to respiratory and immune system
function, heart diseases, or diabetes.36 Moreover, PwD
living in the community often need assistance for their daily
activities, accessing basic goods, or seeking health care,
but such assistance may be restricted under lockdowns.36
Finally, in-person access to general health and rehabilita-
tion services may be restricted owing to lockdown measures
or because routinely available health or rehabilitation
services, beds, and providers have been diverted to the
emergency response to the COVID-19 pandemic.44-47
All accounted, most PwD experience additional disad-
vantages that make them especially vulnerable to the
COVID-19 pandemic (ie, at a greater risk of being dis-
proportionally as well as negatively affected).23,24,32,48 As
such, they may need timely, purposive action from key
stakeholders (eg, policy makers, public health authorities,
civil society) for the health and social inequalities not to be
further widened (but rather reduced) during and after the
COVID-19 pandemic.
The purpose of the study to which this protocol refers is
to review and synthesize the global literature reporting on
PwD who experience at least 1 additional layer of individual
or social vulnerabilities owing to the COVID-19 pandemic.
Specifically, we aim to synthesize any (1) disproportionate
or negative effects reported by the literature, in terms of
greater risks of being infected; more frequent or severe
health consequences from infection; and the greater risks
of a negative social, occupational or economic effect
arising from the COVID-19 pandemic, including any resul-
tant social and economic shockwaves; and (2) action either
taken or recommended, from or for any stakeholders, with
the aim of preventing or mitigating the resultant health,
social, or economic inequalities.
Methods
Design
A scoping review method will be applied.49,50 Scoping re-
views typically address an exploratory research question
toward mapping key concepts, types of evidence, and gaps
in research related to a given area, and often include an
examination of the extent, range, and nature of research
activity in a broad or complex topic, and may be coupled
with a synthesis of the main content or themes covered toinform further policy, practice, and research.50-52 This
scoping review will be based on the Arksey and O’Malley’s
framework49 and subsequent refinements of that frame-
work,51,52 the Joanna Briggs Institute’s methodological
guidance,53 and the Preferred Reporting Items for System-
atic Reviews and Meta-Analysis (PRISMA)eExtensions for
Scoping Reviews reporting guidelines50 in combination with
applicable items from the PRISMA Statement to Equity-
Focused Systematic Reviews (2012).54 For this study
protocol, we follow the applicable items of the PRISMA
Protocols.55 This study protocol has not been registered in
the PROSPERO database (ie, a common database for the
register of systematic reviews)56,57 and the register in other
repositories, such as the Open Science Framework, is
essentially an alternative to the publication of a study
protocol.53
Identifying the research question
In scoping reviews, the research question is a critical first
step that provides the overall rationale for decision-making
about the study design, conduct, and reporting of the re-
view.49,51,52 After initial engagement with the literature
and gaining familiarity with the growing body of knowledge
on the topic area, we developed the following research
questions: (1) What are the amount and characteristics (eg,
publication type, settings addressed) of the global, peer-
reviewed, preprint, and gray literature (eg, official re-
ports) addressing whether or how PwD, who also experience
additional forms or layers of individual or social vulnera-
bility, encounter disproportionate health risks, as well as
health and social consequences of the COVID-19 pandemic?
(2) What does that literature say regarding disproportional
risks and possible actions, either recommended or taken, to
prevent or mitigate identified layers of vulnerability that
PwD may experience as a result of the COVID-19 pandemic?
The map and synthesis of these disproportionate risks
and respective actions taken or recommended, as reported
in the reviewed literature, may inform policy makers,
public health authorities, disability advocates, and other
health and rehabilitation stakeholders, regarding needs or
actions aimed at promoting health equity, avoiding
discrimination, fostering social protection, and promoting
the fulfillment of the human rights of PwD, especially those
facing multiple layers of vulnerability owing to the COVID-
19 pandemic.
Identifying relevant studies
The next step is to develop the search. For this study, 7
databases have been identified for the scientific, peer-
reviewed literature (ie, Medline/PubMed, Web of
ScienceeCore Collection, Scopus, AgeLine, PsycINFO,
CINAHL, and ERIC). We did not include EMBASE, for
example, because it adds to Medline/PubMed essentially at
the biomedical and biochemistry or pharmaceutical levels,
whereas the scope of this study is at a broader level of
health and social effects. Databases searches were con-
ducted in mid-July and will be repeated when the initial
synthesis has been completed, estimated to be 1 or 2
months later. Given the pace of current publications on
COVID-19,58 this update is likely key.
Publications regarding COVID-19 are currently more
recent and more common on preprint servers than in
4 T.S. Jesus et al.peer-reviewed publications.58 Accordingly, we will also
search 3 databases for preprint literature (ie, MedRxiv,
SocArXiv, and PsyArXiv), and this search will be updated
under the same terms. Supplemental appendix S1 (avail-
able online only at http://www.archives-pmr.org/) details
the search strategy for each of the preprint servers. Re-
cords arising from scientific databases and preprint serves
will be exported using a commercial references manager
software (EndNotea), where duplicates will be removed.
Googleb searches also will be performed with combina-
tions of main keywords, as detailed in supplemental
appendix S1. This is aimed at finding key elements of the
gray literature, with a focus on official reports, guidelines,
advice, or recommendations (eg, from national or inter-
national agencies, non-governmental organizations, or
public health authorities). For consistency, the first 40
references from each Google search will be screened,
including those from any social media source. Although not
necessarily exhaustive of the worldwide gray literature,
these searches can provide an indicator of the amount,
scope, and content addressed by that literature. These
searches will also be updated. Moreover, a snowballing
search process (eg, author tracking, referenced sources),
will be conducted for any included reference to identify
any additional records.
Finally, supplied with a preliminary list of inclusions,
members of the American Congress of Rehabilitation Med-
icine’s International Networking Group and Refugee
Empowerment Task Force will be consulted as key in-
formants as to any additional references we may have
missed.Study selection
To be included, any publication must (1) explicitly relate to
the COVID-19 disease or pandemic, which is inclusive of any
direct or indirect health or socioeconomic risks or effects;
(2) explicitly address PwD as a group, related to a subgroup
(eg, based on impairment type or underlying diagnostic
condition), or related to individual cases or circumstances;
and (3) explicitly expose another level of individual or so-
cial vulnerability to the COVID-19 pandemic (ie, beyond the
experience of a disability) or resulting health or socioeco-
nomic consequences.
Working definitions of the key, complex terms
mentioned above (ie, “people with disabilities” and
“vulnerability”) are provided below. For the purpose of this
study, “people with disability,” or PwD, are defined as
those experiencing, at any point across their lifespan, long-
or short-term impairments in 1 or more body structures or
functions (eg, affecting mobility, sensorial, intellectual,
communication, or cognitive function) arising from a health
condition or natural processes (eg, aging) which, in inter-
action with environmental factors, affect the performance
of daily activities or social participation.59-62 We do not
restrict the scope of the underlying health conditions or
impairment types. “Vulnerability” refers to characteristics
or social circumstances of individuals or groups that put
persons at greater risks of being infected, experiencing
more severe health consequences of COVID-19 once infec-
ted, or experiencing more frequent or more severehealth-related and social or economic consequences of the
COVID-19 pandemic, with or without being infected. The
latter can arise from the public health measures aimed at
containing the pandemic (eg, lockdowns), from the subse-
quent global economic crisis, or any resultant policies or
practices.
Examples of groups of people who can be vulnerable to
or disproportionally affected by the COVID-19 pandemic are
described in box 1. The examples in box 1 were constructed
(ie, hypothesized) by the research team, who collectively
hold expertise in disability and rehabilitation studies,
global health, occupational therapy, psychology, ethics,
and sociology. These examples were further informed by a
recent global perspective on who faces health equity risks
in the times of COVID-19,1 a recent editorial in The Lancet
on defining vulnerability or groups vulnerable to the COVID-
19 pandemic,2 a subsequent commentary on vulnerabilities
that arise from social disadvantages entrenched in soci-
eties,14 broader conceptualizations of social disadvantage63
and marginalization,64 and a myriad of recent publications
pinpointing possible health and socioeconomic de-
terminants or consequences of COVID-19, cited in the pa-
per’s introduction.
It is worth noting that the aforementioned list provides
only possible examples of vulnerabilities to the effect of
the COVID-19 pandemic. The list is illustrative and not
intended to be exhaustive or deterministic. Although it
aims to help guide more reliable selection decisions, it also
aims not to strictly dictate them. As a recent editorial in
The Lancet eloquently noted, “amid the COVID-19
pandemic, vulnerable groups are not only elderly people,
those with ill health and comorbidities, or homeless or
underhoused people, but also people from a gradient of
socioeconomic groups that might struggle to cope finan-
cially, mentally, or physically with the crisis (p. 1089).”2
Overall, the publications reviewed will be deemed to
address “vulnerability” if they cover any individual or group
characteristics or social circumstances explicitly or
implicitly linked to a disproportional effect of the COVID-19
pandemic. If the article fails to establish this connection,
even if any of the listed characteristics are mentioned, it
will be excluded. However, publications will be included if
they address vulnerabilities and social disadvantages as an
umbrella term (eg, not with a focus on specific groups) or
address many of the above at the same time, not neces-
sarily with clear boundaries. In fact, vulnerabilities and
social disadvantages, such as those listed previously, are
often synergistic and mutually reinforced.32,63,65,66 Finally,
people can become vulnerable depending on the public
health approach, the policy response, or lack thereof, and,
hence, the eligibility decisions need to consider vulnera-
bility issues for the reported context.
Two independent reviewers (SK and SB) will conduct
both the level 1 screening (titles and abstract) and level 2
screening (full-text review with eligibility decisions). Each
of these processes will be preceded by a pilot screening in a
5% to 10% random sample of references, in which an 80%
agreement, or greater, must be achieved among the re-
viewers for the full screening to take place. Training and
further pilot screening might be required until the minimum
threshold is achieved. The process will be supervised by the
guarantor of the review (T.J.), who has extensive
Disability and COVID-19 vulnerabilities 5experience leading scoping reviews. The same researcher
decides on any remaining disagreements while calling for
the support of any particular coauthor, as needed, ac-
cording to one’s expertise. Finally, depending on the
number of references to be screened, additional reviewers
may be engaged in the performance of the 2 independent
reviewer roles, and will be subject to the same criteria.
Peer-reviewed or preprint publications in 6 languages
(ie, English, French, Spanish, Greek, Russian, and Portu-
guese) will be included in the scoping review. Publications
in Mandarin or Arabic languages, for example, will be
excluded owing to lack of these language skills within the
research team. The review of articles in languages other
than English by a reviewer not primarily assigned with in-
dependent reviewer tasks will be directly overseen by the
guarantor of the review (T.J.).
For the gray literature resulting from Google searches,
we will include reports, guidelines, recommendations, or
position papers from official sources or representative in-
stitutions. This includes, for example, governments, na-
tional or international agencies, public health authorities,
national or international nongovernmental organizations,
human and disability rights observatories, representative
associations of disabled persons, and associations or con-
federations of professionals who intervene with or advo-
cate for the health and well-being of PwD. We will only
cover the gray literature in the English language for several
reasons. First, we aim to expedite the review process to
provide timely, actionable results that could have an effect
on the response to the current pandemic. Restricting the
coverage of the gray literature, but not restricting the in-
clusion of key English-language or international-level gray
literature, is a way to achieve this, along with the backdrop
of comprehensive searches in scientific databases and
preprint servers inclusive of 6 languages. Second, the
search and preliminary screening of the gray literature
through Google searches will be conducted by a single
researcher, whereas a search and preliminary screening in 6
different languages would need to be conducted by several
researchers to accommodate varying languages. In addition
to being impractical, this would also lead to a greater
likelihood of a large inter-rater variability.
Peer-reviewed publications or preprints based on study or
publication type (ie, empirical research, peer-reviewed pub-
lished abstracts and letters to the editor) will be included.
There are also no time limits for the inclusion of papers.Charting the data
Using a data extraction form and structure constructed by
the research team, formal data elements (eg, publication
type, source) will be extracted by 1 of the researchers
(S.K.), with a random sample of 5% verified by another
(J.B.). This will follow a predetermined coding structure
elaborated by the research team.
Regarding the content of the literature, 2 independent
reviewers (S.K. and S.B.) will extract text quotations on any
added risk for or disproportionate effect of the COVID-19
pandemic (eg, on health, socioeconomic, and occupational
dimensions) on PwD who also experience other vulnerabil-
ities or social disadvantages. Any activities, taken as well asrecommended, to prevent or mitigate the disproportionate
effect and promote equity for PwD will also be extracted,
for separate text boxes within the data extraction tables.
Collating, summarizing, and reporting the results
The findings will incorporate a summative description of the
amount and range of the related literature. Descriptive sta-
tistics will be used (eg, percentages) to address issues of
publication type, country(or countries) addressed, the source
(eg, databases of peer-reviewed literature, preprint servers,
or Google searches on the gray literature), and different type
of impairments (eg,mobility, cognitive function, intellectual,
developmental, sensorial), or the disabling of health condi-
tions (eg, neurologic, cardiothoracic, musculoskeletal, or
specific diagnosis), when applicable.
The number and percentage of the included publications
that address the disproportionate risks of COVID-19 infection,
the greater health effects from COVID-19 infection, or the
greater socioeconomic or occupational injustices experi-
enced or likely experienced by people with disabilities and
other vulnerabilities in the pandemic scenario will be
described. The same analysis will be applied to publications
describing actions taken and recommended to be taken, to
address any disproportional risk or effect. Moreover, we will
quantify the publications addressing individual versus social
vulnerability (ie, vulnerability from one’s age, health condi-
tion, or other individual circumstances vs vulnerabilities that
arise from group- or society-level circumstances), including
from broader policies or public health responses to the
COVID-19 pandemic. At a more granular level, the number of
publications according to the types of vulnerability described
in box 1, or any evolving adaptation from it, will be analyzed.
The analyses described in previous paragraphs will be
derived from an initial, deductive coding, that is, based on
a predefined coding structure built by the research team,
performed independently by the 2 data extractors (S.K. and
S.B.), along with any supporting qualitative notes or text
quotations. These supportive notes will enable the scrutiny
by the remaining elements of the research team. Final
decisions on any disagreement in the ratings will be made
by the guarantor of the review, who has led the design but
who had no primary reviewer roles (T.J.).
Finally, a qualitative thematic analysis67 will be con-
ducted from the content (ie, text quotations) extracted
from the literature, on the disproportionate risks of COVID-
19 infection; health effects from COVID-19 infection; so-
cial, economic or occupational injustices or inequalities
widened or possibly widened as a result of the public health
and economic crisis, or the policy and practices in response
to that; and the actions taken and actions recommended to
be taken to protect PwD and those with other vulnerabil-
ities during the pandemic.
Although a table with a synthesis of findings, per study or
category above, can be provided (eg, as supplementary
material), the main results will be reported in the form of
new, aggregative themes that highlight emergent knowl-
edge and possibly novel patterns and configurations of that
knowledge after juxtaposition of the raw findings from the
5 categories. Beyond coding, this analytical approach in-
volves interpretation, finding overarching themes, new
Box 1. Examples of groups of people who may be vulnerable to the COVID-19 pandemic, apart from people experiencing a
disability, organized by type of vulnerability
Health- and age-related characteristics
People with comorbid, chronic, or secondary health conditions, including those with an effect on the respiratory,
cardiovascular, or immune function. These persons can be more severely affected by the COVID-19 disease.
People at an older age or with frail health conditions, including people with a history of debilitating health conditions (eg,
dementia) and people with history of substance abuse. These persons can also be more severely affected by the direct
health consequences of the COVID-19 disease, or can be subject to relapses or aggravation of their health status or
functional limitations by the lack of support or assistance that may arise from the pandemic or resultant lockdowns.
People facing social isolation and lack of social support from lockdown or other preventive measures, especially older
populations who can be subject to tighter or longer physical proximity restrictions. These persons can be vulnerable to
negative psychosocial effects of the COVID-19 pandemic, including in terms of mental health, disfranchisement,
occupational injustice, and social isolation.
People with depression or other mental health conditions (or who are at risk of having mental health conditions) can have their
mental health status aggravated by the health or socioeconomic effects of COVID-19. These include any suicidal ideation or
behaviors arising from the unemployment, financial, and other stresses coming from the public health and economic crisis.
Children with sensory processing difficulties who have unusual responses to sensory input can have difficulty coping with
activities of hand washing and wearing masks.
Access to health services and equipment
People who are uninsured, underinsured, or who have no universal access to health care, including care directly related to
COVID-19. This includes capacity to get (timely) diagnostic tests for COVID-19 or for accessing adequate treatment, including
access to ventilators.
People living in medically underserved or undersupplied areas (eg, rural or remote locations with limited access to diagnostic
and treatment facilities, face masks, or other personal protective equipment).
People with no or reduced access to transportation facilities or personal assistance services as a means to satisfy health and
functional needs or access to health care.
People whose need for timely access to assistive devices has been affected by disruptions in the supply chain or distribution of
these products as a result of the COVID-19 pandemic and labor restrictions.
Living and housing conditions
People who are homeless, homebound, underhoused, and who thereby may struggle to ensure physical distancing and adequate
hygiene measures.
People living in densely populated communities or households, who may struggle to ensure physical distancing, including during
mandatory or self-imposed quarantine measures.
People institutionalized, including the hospitalized and those living in nursing homes or residential facilities, who are subject to
infection spread within the institutional environment.
Prisoners or those who are incarcerated and in detainment or correctional facilities, where maintaining physical distancing and
containing the spread of the disease can be complex or unattainable.
People without (reliable) access to clean water and soap for the recommended hygiene measures.
People living in locations whose living conditions or social order have been threatened by military conflict, natural disasters, or
other humanitarian crises.
Income-related
Populations identified as pertaining to low- or middle-income countries, regions, or areas, who may struggle to financially
access health care beyond any universally assured, afford a living with the loss of income associated to preventive measures
(eg, periods of lockdown), or in which lockdown measures for containing the pandemic have not been taken, at the
population level, for economic reasons.
People otherwise facing poverty or with no stable or sufficient income, economically exploited, underpaid, working in the
informal economy, without access to a paid sick (or quarantine) leave, or the so-called working poor, who may have limited
to no capacity to afford lockdowns and may have higher exposure to the socioeconomic shockwaves of the COVID-19
pandemic, without sizeable social protection.
Access to developmental-related services
Children and youths with special education needs may have important restrictions in the in-person participation in school and
other (eg, therapeutic) activities, restricted by lockdown measures. Virtual schooling or therapy may be demanding,
unpractical, or less effective for many (eg, requiring caregiving assistance, skills in communication and information
technologies from the caregivers or the children, digital devices and internet access, performed without tactile or bodily
sensation such as that provided by a hands-on therapeutic input at the backdrop of children with sensory processing issues).
Children and youths with developmental disabilities as well as their informal caregivers may have restricted access to health,
social, or child protection services they may need to rely on, because of lockdowns or because these services and resources
have been prioritized for addressing acute needs arising from the COVID-19 pandemic.
(continued on next page)
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Box 1. (continued )
Children and youths with developmental disabilities may be exposed to increased adverse childhood experiences such as abuse
and neglect, exacerbated by COVID-19 related stress and the effect on caregivers and family.
Children and youths with developmental disabilities may have restricted opportunities to develop social abilities, interpersonal
relationships, and other key developments as a result of the restricted social and physical contact, or may have difficulty
adjusting to a suddenly altered routine.
Working roles and conditions
People with frontline, essential jobs (eg, in health care, pharmacy, grocery stores, transports), which need to be carried out
even during lockdown periods.
People otherwise not able to telework, either by the nature of their job, lack of skills in using information and communication
technologies, or lack of reasonable accommodations.
People who are unemployed, underemployed, laid-off, pressured to anticipate retirement, or pressured to take over frontline
essential jobs without enough preparation, may face economic or health risks, including mental health risks.
Minority or socially disadvantaged populations
Refugees or asylum seekers as well as migrants, including those who are undocumented, may face cultural or language barriers
to understand or comply with public health measures, poor living or preventive isolation conditions, poor to no access to
health care, and poor economic resources, among other drivers of vulnerability and social disadvantage, likely exacerbated
during a pandemic scenario.
People from minorities or socially disadvantaged races (eg, African Americans), ethnicities, minority religions within an area, or
indigenous populations, who may lower working and livelihood conditions, lower access to health care, and cultural
differences not accounted for in public health measures designed with the majorities or better-off in mind.
People who are victims of interpersonal or domestic violence, coercion, or sex-based prejudice may face health care access
restrictions, may be unwillingly exposed to physical contact, or may be vulnerable to violence during lockdown periods.
Disability and COVID-19 vulnerabilities 7meanings, and looking for co-occurring patterns in the data
not only semantically present but also latent.
Although 3 authors (S.K., S.B., and T.J.) will build the
initial thematic categories and synthesis, all will iteratively
review the themes according to the data extracted and their
own interpretative lens. The diversity of the backgrounds of
the research authors, previously noted, will enrich this
iteration, and help produce amore refined, transdisciplinary
synthesis. Yet, to promote a theoretical integration and
avoid a miscellaneous of unconnected perspectives, an
overarching standpoint or theoretical cement is defined a
priori. Within this regard, the thematic synthesis can be
informed, among others, by an equity-oriented perspec-
tive,1,24,68,69 systems-based thinking,70-76 complex science
principles,77-81 human-rights based perspectives,82,83 social
and occupational justice lenses,84-86 and disability-inclusive
and universal design thinking,37,87-90 all applied to an inte-
grative development of health and social policies1,8,14,24 that
is needed now more than ever.91,92
Experts’ consultation
The consultation of experts is an optional yet recommended
step in scoping a review.51 The goals can include helping to find
relevant publications and reinterpreting the review results and
their implications. Experts for both steps will be consulted.
Regarding the finding of relevant publications, as
mentioned previously, members of the American Congress
of Rehabilitation Medicine’s International Networking
Group and Refugee Empowerment Task Force, a diverse
group in terms of background and expertise, will be sup-
plied with a preliminary list of inclusions and consulted as
key informants on any additional reference potentially
fitting the inclusion criteria we may have missed. Only the
members of that group who are not authors of the paperwill be consulted. Recommendations can address the gray
literature, including for any group of people, world loca-
tion, culture, or other variable potentially underrepre-
sented. Although this process might not ensure exhaustive
coverage of the gray literature, it may contribute to closing
gaps in the representativeness of the reviewed information.
Finally, the same group of experts will be afforded with the
opportunity to comment or suggest amendments on the first
complete draft of the results and discussion, which will be
considered by the research team as a source of improve-
ments in the final manuscript.
Strengths, weaknesses, and dissemination
This scoping review examines a complex topic and is
grounded in a carefully designed, published scoping review
protocol, which adds to the strength and transparency of
the methodology. Two independent reviewers will be used
across the screening decisions and key data extractions.
The thematic analysis will integrate a diversity of theo-
retical and disciplinary perspectives, facilitated by the
heterogenic background and expertise of the research au-
thors. Last but not least, the topic is timely and can likely
inform policy makers, public health authorities, and other
stakeholders on any action needed to promote equity and
disability-inclusive responses to the pandemic and the
resultant socioeconomic shockwaves. With an expedited
yet comprehensive review process, one can expect that the
results of this review will be instrumental for the global
public health and economic crisis situation arising currently
as a result of the COVID-19 pandemic, as well as informing
the preparedness for any future global public health crises.
A limitation of this work is that a quality appraisal of the
included studies, which is typical in scoping reviews, will not
be performed. On one hand, as this is a very recent topic, we
8 T.S. Jesus et al.do not expect to review many planned or higher-level sci-
entific evidence (eg, from protocol-based systematic re-
views, longitudinal, or experimental studies). However, we
expect to includeagreater number of case studies or reports,
analyses of public domainorexisting researchdata, practice-
based cross-sectional research, and even perspective pa-
pers. Indeed, commentaries, letters, and editorials have
been prevalent in the peer-reviewed literature related to
COVID-19.58 On the other hand, we aim to address explor-
atory research questions andmap the breadth of the existing
literature on a topic, not to review the efficacy or effec-
tiveness of interventions (or diagnostic tests) or test a pre-
specified hypothesis, for which a quality assessment,
grading, and related eligibility decisions would be key. Also,
there is a risk of not being exhaustive or representative of the
world’s different cultures, responses, or perspectives in the
review of gray literature, in part owing to the restriction of
English-languagematerial. This decision wasmade to ensure
the feasibility and timeliness of the execution of this review,
as the issue of timeliness is key for the results to be action-
able right now, in the context of the COVID-19 pandemic.93,94
This is, however, a restricted compromise, compared with
rapid review methods addressing COVID-19 issues,93 and
what is typical in rapid review approaches for pressing health
policy issues, even apart from a pandemic scenario.95 For
example, 2 independent reviewers are involved across both
stages of the scoping review, and a study protocol will be
published, which is still uncommon in scoping reviews,
especially in the rehabilitation field, even without a “rapid”
label.96 Although the process is expedited and does not
include the gray literature in languages other than English, in
essence we will conduct a full-fledged scoping review,
including 6 languages for the peer-reviewed and preprint
literature. As a major limitation, PwD have not been con-
sulted as experts. Consulting experts is an optional step. For
feasibility and timeliness, only experts from an existing
group will be consulted. This current restriction does not
prevent that any missing perspectives (eg, from PwD or their
representatives) could, and probably will, be collected and
integrated later, over the scoping review results.
The dissemination of the study results will be made
through a peer-reviewed publication and through newsletter
or policy briefs expanding from the action of the American
Congress of Rehabilitation Medicine’s Refugee Empower-
ment Task Force, and its broader International Networking
Group.Suppliers
a. EndNote; Clarivate Analytics.
b. Google Search; Google LLC.
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